Physician profile
Sonya Flowers
NPI 1558532630
$10,352.09
in general payments reported to CMS, 2019-2025
32 companies · $2,218 in 2025
The $2,218 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,302 · 2020: $433 · 2021: $66.19 · 2022: $1,046 · 2023: $2,286 · 2024: $2,001 · 2025: $2,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,349 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,349.13 |
| Education | $155.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,641.09 | 2019-2025 | |
| Janssen Biotech, INC. | $1,040.80 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $736.47 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $650.73 | 2019-2025 | |
| Pfizer INC. | $632.11 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $610.76 | 2019-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $557.31 | 2019-2025 | Aklief, Nemluvio, Oracea |
| Genzyme Corporation | $553.25 | 2019-2025 | |
| Biofrontera INC. | $526.01 | 2019-2025 | |
| Lilly USA, LLC | $460.86 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Incyte Corporation | $374.72 | 2022-2025 | Opzelura |
| Ucb, INC. | $347.42 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $316.33 | 2019-2025 | Otezla |
| Leo Pharma INC. | $259.60 | 2019-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $245.81 | 2023-2025 | Zoryve |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $239.95 | 2019-2024 | Jublia, Arazlo, Cabtreo |
| Almirall LLC | $236.58 | 2019-2025 | Seysara, Klisyri |
| E.R. Squibb & Sons, L.L.C. | $203.80 | 2022-2025 | Sotyktu |
| Encore Dermatology INC. | $155.97 | 2019 | |
| Celgene Corporation | $113.15 | 2019 | |
| Dermira, INC. | $69.26 | 2019-2020 | |
| Dermavant Sciences, INC. | $64.29 | 2023-2024 | Vtama |
| Organon LLC | $55.98 | 2025 | Vtama |
| Epi Health, LLC | $50.70 | 2019 | |
| Medtronic, INC. | $43.22 | 2024 | Sinuva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.20 | 2023-2024 | Cyltezo |
| Genentech USA, INC. | $34.58 | 2024 | Erivedge |
| Kerecis Limited | $19.04 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Fidia Pharma USA INC. | $18.46 | 2024 | |
| Botanix Sb INC | $17.83 | 2025 | Sofdra |
| Dusa Pharmaceuticals, INC. | $17.81 | 2019 | |
| Glenmark Therapeutics INC. | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Flowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.